Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Rational Analyst -- Ignore unavailable to you. Want to Upgrade?

To: HeyRainier who wrote (993)	5/26/1998 9:43:00 PM
From: Scott H. Davis	Read Replies (1) \| Respond to of 1720

[Market chat question] Rainier, do I get the impression you think we're in for further declines, and what would you look at for signs of a positive reversal, even intraday tomorrow? Several issues look to be "on sale" based on closing prices, but I'm wondering if there will be further "mark downs" tomorrow. I almost picked up on SAVLY late last fall/winter in high 20s/low 30s, kicked myself in retrospect (thought it was over priced then) Now its getting back down to a point where it may be reasonable. ALNK is another one, MRVC and ISIP too. Your thoughts?

To: HeyRainier who wrote (993)	5/26/1998 9:57:00 PM
From: Scott H. Davis	Respond to of 1720

[TA assessment request - Titan Pharmaceuticals (TTNP)]TTNP has broken out of the declining trendline, following good news from three cancer vaccines in phase I/II clinical trials, thus the risk/reward picture is materially improved. TITAN PHARMACEUTICALS INC. Reports Positive Preliminary Results in Three Phase I/II Clinical Cancer Vaccine Trials biz.yahoo.com I can handle the business case assessment, but I was wondering if some of the "TA heavyweights" would be willing to venture an opinion. TIA, Scott BTW, any other biotech followers active on this thread?